Terns Pharmaceuticals, Inc. — Director's Dealing 2021

Feb 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2021-02-24

Reporting Person: GORDON CARL L (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-24	Stock Option (Right to Buy)	$22.06	A	25000	Acquired	2031-02-23	Common Stock (25000)	Direct

Footnotes

F1: 1/3rd of the shares subject to the option vest on the first anniversary measured from February 24, 2021 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.